BioSpace News Archive

Drug Development

VBL Therapeutics Release: Phase I/II Data of VB-111 Demonstrate Anti-Tumor Effects With Increase in Overall Survival With This Anti-Angiogenic Gene Therapy, in Patients With Recurrent Glioblastoma Multiforme

June 3, 2013
·
1 min read
Fuse Science, Inc. CEO Interviewed by the Stock Radio

June 3, 2013
·
2 min read
Drug Development

AstraZeneca PLC Advances PARP Inhibitor Into Phase 3 Trial With BRACAnalysis®

June 3, 2013
·
1 min read
Teva Pharmaceutical Industries Limited’s Lonquex®(XM22 lipegfilgrastim) Recommended for Approval in the EU for the Reduction of Chemotherapy-Induced Neutropenia (CIN)

June 3, 2013
·
1 min read
Biotech Beach

Agendia BV Release: Ground-breaking Research Identifies Molecular Subtyping as a Key to Determining Prognosis and Benefit of Chemotherapy for Breast and Colorectal Cancers

June 3, 2013
·
2 min read
Deals

Elan Corporation PLC Issues Response Document Further Detailing Inadequacy of Royalty Pharma’s Revised Offer

June 3, 2013
·
1 min read
BioMidwest

Cell-Free DNA Accurately Correlates With Breast Cancer DNA, Chronix Biomedical, University of Texas MD Anderson Cancer Center Study

June 3, 2013
·
1 min read
Drug Development

Exelixis, Inc. Presents COMETRIQ (cabozantinib) Clinical Trial Data in Patients With Progressive, Metastatic Medullary Thyroid Cancer

June 3, 2013
·
1 min read
Pharm Country

Octapharma USA, Inc. President Flemming Nielsen Named Humanitarian Man of the Year by Hemophilia Association of NJ

June 3, 2013
·
1 min read
Data From a New Study on DiagnoCure’s GCC Assay Show Positive Results for Predicting Risk of Colon Cancer Recurrence

June 3, 2013
·
6 min read